Hyperprolactinaemia and antipsychotics
- 期刊名称BJPscyh Advances
- 作者Nelson, J. C.; Bell, P. M.; Guy, S. T.
- 卷第21卷
- 期第4期
- 印刷ISSN2056-4678
- 电子ISSN2056-4686
- 文件大小56.51KB
- 发表时间2015-07-01
- DOI10.1192/apt.bp.113.012088
- 页码240-241
NO-H2S interactions involve cGMPPapapetropoulos, Andreas · BMC Pharmacology and Toxicology · 2013
Natriuretic peptides and fat metabolismCollins, Sheila · BMC Pharmacology and Toxicology · 2013
BMCPharmacology and Toxicologyreviewer acknowledgement 2014Morrey, Christopher · BMC Pharmacology and Toxicology · 2015
BMC Pharmacology and Toxicologyreviewer acknowledgement 2015Morrey, Christopher · BMC Pharmacology and Toxicology · 2016
cGMP and cardiac hypertrophyRuwan K Perera,Hariharan Subramanian,Alexander Froese… · BMC Pharmacology and Toxicology · 2015
Reviewer acknowledgement 2013Helena C Flemyng · BMC Pharmacology and Toxicology · 2014
Chronic natriuretic peptide protein therapeuticsChen, Horng H; Cataliotti, Alessandro; Burnett, John C · BMC Pharmacology and Toxicology · 2013
sGC redox regulation and asthmaDennis J Stuehr,Arnab Ghosh,Cynthia J Koziol-White… · BMC Pharmacology and Toxicology · 2015